Understanding the Molecular Basis for the Inhibition of the Alzheimer's Aβ-Peptide Oligomerization by Human Serum Albumin Using Saturation Transfer Difference and Off-Resonance Relaxation NMR Spectroscopy
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Human serum albumin (HSA) inhibits the formation of amyloid beta-peptide (Abeta) fibrils in human plasma. However, currently it is not known how HSA affects the formation of the highly toxic soluble diffusible oligomers that occur in the initial stages of Abeta fibrillization. We have therefore investigated by solution NMR the interaction of HSA with the Abeta(12-28) peptide, which has been previously shown to provide a reliable and stable model for the early prefibrillar oligomers as well as to contain key determinants for the recognition by albumin. For this purpose we propose a novel NMR approach based on the comparative analysis of Abeta in its inhibited and filtrated states monitored through both saturation transfer difference and recently developed nonselective off-resonance relaxation experiments. This combined NMR strategy reveals a mechanism for the oligomerization inhibitory function of HSA, according to which HSA targets preferentially the soluble oligomers of Abeta(12-28) rather than its monomeric state. Specifically, HSA caps the exposed hydrophobic patches located at the growing and/or transiently exposed sites of the Abeta oligomers, thereby blocking the addition of further monomers and the growth of the prefibrillar assemblies. The proposed model has implications not only for the pharmacological treatment of Alzheimer's disease specifically but also for the inhibition of oligomerization in amyloid-related diseases in general. In addition, the proposed NMR appr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CEST approach is an ideal method for probing equilibria between NMR visible (detectable) and invisible (undetectable) states of proteins, including low molecular weight species that are transiently bound to slow-tumbling high-molecular-weight complexes, which indeed cannot be observed directly in solution NMR experiments as a result of excessive line broadening.”
From Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour (2014) · cites this paper as [26]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Amyloid β-Peptide Is Transported on Lipoproteins and Albumin in Human Plasma
Biere, A. L., Ostaszewski, B., Stimson, E. R., Hyman, B. T., Maggio, J. E., & Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32916 · Cited by 331
Research works printed but not linked: 35
- Van Gool W. A., 1995, Ann. Neurol., 37, 230, 10.1002/ana.410370221 · DOI · Paper page
- Haass C., 1993, J. Cell, 75, 1042
- Haass C., 1993, J. Ann. N.Y. Acad. Sci., 695, 116, 10.1111/j.1749-6632.1993.tb23037.x · DOI · Paper page
- Bohrmann B., 1999, J. Biol. Chem., 274, 15995, 10.1074/jbc.274.23.15990 · DOI · Paper page
- 1996, Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W.; Gilman, A. G. Goodman & Gilman's The Pharmacological Basis of Therapeutics
- Kuo Y. M., 2000, Biochem. Biophy. Res. Commun., 268, 756
- Klein W. L., 2004, Neurobiol. Aging, 25, 580, 10.1016/j.neurobiolaging.2004.02.010 · DOI · Paper page
- Jarvet J., 2000, J. Am. Chem. Soc., 122, 4268, 10.1021/ja991167z · DOI
- Mansfield L. S., 1998, Biochim. Biophys. Acta, 1382, 265, 10.1016/S0167-4838(97)00162-3 · DOI
- Zhang S., 1998, J. Folding Des., 3, 422
- McLaurin J., 2000, J. Struct. Biol., 130, 270, 10.1006/jsbi.2000.4289 · DOI · Paper page
- Tycko R., 2003, Prog. Nucl. Magn. Reson. Spectrosc., 42, 68, 10.1016/S0079-6565(03)00003-7 · DOI
- Zagorski M. G., 1999, Methods Enzymol., 309, 204, 10.1016/S0076-6879(99)09016-3 · DOI
- Ippel J. H., 2002, Proc. Natl. Acad. Sci. U.S.A., 99, 8653, 10.1073/pnas.132098999 · DOI
- Narayanan S., 2001, Proc. Natl. Acad. Sci. U.S.A., 100, 9291
- Mayer M., 2001, J. Am. Chem. Soc., 123, 6117
- Mayer M., 2002, J. Am. Chem. Soc., 124, 13377
- Esposito V., 2005, J. Am. Chem. Soc., 127, 9359, 10.1021/ja051714i · DOI
- Milojevic J., 2006, J. Phys. Chem. B, 110, 20670, 10.1021/jp063194z · DOI
- Wuthrich K., 1986, NMR of Proteins and Nucleic Acids, 10.1051/epn/19861701011 · DOI · Paper page
- Palmer A. G., 1998, Columbia University: 630 West 168th Street
- Narayanan S., 2005, Biochemistry, 44, 1452
- Bernstein S. L., 2005, J. Am. Chem. Soc., 127, 2084, 10.1021/ja044531p · DOI · Paper page
- Riek R., 2001, Eur. J. Biochem., 268, 5936, 10.1046/j.0014-2956.2001.02537.x · DOI · Paper page
- Zhang S., 2000, J. Struct. Biol., 130, 141, 10.1006/jsbi.2000.4288 · DOI · Paper page
- Tiana G., 2004, J. Chem. Phys., 120, 8317, 10.1063/1.1689293 · DOI
- Mastrangelo I. A., 2006, J. Mol. Biol., 358, 119, 10.1016/j.jmb.2006.01.042 · DOI · Paper page
- Luhrs T., 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 17347, 10.1073/pnas.0506723102 · DOI · Paper page
- Chimon S., 2005, J. Am. Chem. Soc., 127, 13473, 10.1021/ja054039l · DOI
- Hoshi M., 2003, Proc. Natl. Acad. Sci. U.S.A., 100, 6375, 10.1073/pnas.1237107100 · DOI · Paper page
- Westlind-Danielsson A., 2001, Biochemistry, 40, 14743, 10.1021/bi010375c · DOI · Paper page
- Esler W. P., 2000, Biochemistry, 39, 6295, 10.1021/bi992933h · DOI · Paper page
- Evans K. C., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 767
- Dedmon M., 2005, J. Biol. Chem., 280, 14740, 10.1074/jbc.M413024200 · DOI · Paper page
- Come J. H., 1993, Proc. Natl. Acad. Sci. U.S.A., 90, 5963
Cited by
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Fusco, G., Chen, S. W., Williamson, P. T. F., Cascella, R., Perni, M., Jarvis, J. A., Cecchi, C., Vendruscolo, M., Chiti, F., Cremades, N., et al. (2017) · Science · doi:10.1126/science.aan6160 · Cited by 673
Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies
Nasica-Labouze, J., Nguyen, P. H., Sterpone, F., Berthoumieu, O., Buchete, N.-V., Coté, S., De Simone, A., Doig, A. J., Faller, P., Garcia, A., et al. (2015) · Chemical Reviews · doi:10.1021/cr500638n · Cited by 584
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., & Veglia, G. (2014) · Nature Communications · doi:10.1038/ncomms4827 · Cited by 528
C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction
Lautenschläger, J., Stephens, A. D., Fusco, G., Ströhl, F., Curry, N., Zacharopoulou, M., Michel, C. H., Laine, R., Nespovitaya, N., Fantham, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03111-4 · Cited by 334
Structural basis of synaptic vesicle assembly promoted by α-synuclein
Fusco, G., Pape, T., Stephens, A. D., Mahou, P., Costa, A. R., Kaminski, C. F., Kaminski Schierle, G. S., Vendruscolo, M., Veglia, G., Dobson, C. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12563 · Cited by 280
Metadata
- Authors
- Milojevic, J., Esposito, V., Das, R., & Melacini, G.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-03-17
- Volume
- 129
- Issue
- 14
- Pages
- 4282-4290
- ISSN
- 0002-7863
- 1520-5126
- Cited by
- 117
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the Molecular Basis for the Inhibition of the Alzheimer's Aβ-Peptide Oligomerization by Human Serum Albumin Using Saturation Transfer Difference and Off-Resonance Relaxation NMR Spectroscopy. https://app.cochat.ai/papers/10.1021/ja067367+
- The paper
- Milojevic, J., Esposito, V., Das, R., & Melacini, G. (2007). Understanding the Molecular Basis for the Inhibition of the Alzheimer's Aβ-Peptide Oligomerization by Human Serum Albumin Using Saturation Transfer Difference and Off-Resonance Relaxation NMR Spectroscopy. Journal of the American Chemical Society. https://doi.org/10.1021/ja067367%2B
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.